Years since HCV diagnosis, median (IQR)
|
-
|
10 (6-14)
|
-
|
HCV genotype, N (%)
|
-
| |
-
|
1
| |
577 (56.0)
| |
2
| |
39 (3.8)
| |
3
| |
187 (18.1)
| |
4
| |
225 (21.8)
| |
5 or other
| |
3 (0.3)
| |
HCV plasma RNA (Log10) (IU/ML), median (IQR)
|
-
|
6.2 (5.7-6.5)
|
-
|
Past anti HCV therapy, N (%)
| | | |
Interferon alone
|
40 (3.4)
|
33 (3.1)
|
7 (5.5)
|
Interferon+ ribavirin
|
93 (7.9)
|
65 (6.2)
|
28 (22)
|
Pegylated interferon plus ribavirin
|
365 (31.1)
|
273 (26.0)
|
92 (72.5)
|
Cirrhosis*, N (%)
|
255 (25.2)
|
229 (25.0)
|
26 (26.8)
|
Documented decompensated liver disease, N (%)
|
32 (2.7)
|
27 (2.6)
|
5 (3.9)
|